Evidence map›Paper›PMID 37530483›Full record

ArticlePediatric pulmonology2023

High flow nasal cannula use is associated with increased hospital length of stay for pediatric asthma.

Colin Rogerson, Arthur Owora, Tian He, Aaron Carroll, Titus Schleyer, Samer AbuSultaneh, Wanzhu Tu, Eneida Mendonca

Open access · bronzeAbstract read
In one paragraph

Article in Pediatric pulmonology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Colin RogersonIndiana University School of Medicine, Indianapolis, Indiana, USA.ORCID 0000-0001-5251-2399
Arthur OworaIndiana University School of Medicine, Indianapolis, Indiana, USA.
Tian HeRegenstrief Institute, Center for Biomedical Informatics, Indianapolis, Indiana, USA.
Aaron CarrollIndiana University School of Medicine, Indianapolis, Indiana, USA.
Titus SchleyerDepartment of Biostatistics, Indiana University-Purdue University, Indianapolis, Indiana, USA.
Samer AbuSultanehIndiana University School of Medicine, Indianapolis, Indiana, USA.
Wanzhu TuRegenstrief Institute, Center for Biomedical Informatics, Indianapolis, Indiana, USA.
Eneida MendoncaIndiana University School of Medicine, Indianapolis, Indiana, USA.
Indiana University School of MedicineRegenstrief Institute · USCincinnati Children's Hospital Medical Center · USIndiana University – Purdue University Indianapolis · US

Funding

Developing a Childhood Asthma Risk Passive Digital MarkerK01HL166436 · NHLBI · TRUSTEES OF INDIANA UNIVERSITY · PI OWORA, ARTHUR HAMIE · 2023 to 2024
$324k
Effect of iron status trajectories on lung function and asthma riskR03HS029088 · AHRQ · TRUSTEES OF INDIANA UNIVERSITY · PI OWORA, ARTHUR HAMIE · 2022 to 2024
$110k
AHRQ HHS R03 HS029088NHLBI NIH HHS K01 HL166436
6 · The paper itself

Abstract

backgroundHigh flow nasal cannula (HFNC) is a respiratory device increasingly used to treat asthma. Recent mechanistic studies have shown that nebulized medications may have reduced delivery with HFNC, which may impair asthma treatment. This study evaluated the association between HFNC use for pediatric asthma and hospital length of stay (LOS).

methodsThis was a retrospective matched cohort study. Cases included patients aged 2-18 years hospitalized between January 2010 and December 2021 with asthma and received HFNC treatment. Controls were selected using logistic regression propensity score matching based on demographics, vital signs, medications, imaging, and social and environmental determinants of health. The primary outcome was hospital LOS.

resultsA total of 23,659 encounters met eligibility criteria, and of these 1766 cases included HFNC treatment with a suitable matched control. Cases were well-matched in demographics, social and environmental determinants of health, and clinical characteristics including use of adjunctive asthma therapies. The median hospital LOS for study cases was significantly higher at 87 h (interquartile range [IQR]: 61-145) compared to 66 h (IQR: 43-105) in the matched controls (p < 0.01). There was no significant difference in the rate of intubation and mechanical ventilation (8.9% vs. 7.6%, p = .18); however, the use of NIV was significantly higher in the cases than the control group (21.3% vs. 6.7%, p < .01).

conclusionIn this study of children hospitalized for asthma, HFNC use was associated with increased hospital LOS compared to matched controls. Further research using more granular data and additional relevant variables is needed to validate these findings.

Indexed as

AsthmaNoninvasive VentilationRespiratory InsufficiencyCannulaChildCohort StudiesHospitalsHumansLength of StayOxygen Inhalation TherapyRetrospective Studiescritical careinformaticspediatricspulmonology

Identifiers

PMID37530483
PMCPMC11830989
OpenAlexW4385476426

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.